Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Appointed director
|
|
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/17/2023 |
4
| Vogt Frederick G (Interim CEO & General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 8,851 shares
@ $7.76, valued at
$68.7k
Exercised 20,834 restricted stock units
@ $0 |
|
| 07/17/2023 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,395 shares
@ $7.76, valued at
$10.8k
Exercised 2,813 restricted stock units
@ $0 |
|
| 07/17/2023 |
4
| BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,395 shares
@ $7.76, valued at
$10.8k
Exercised 2,813 restricted stock units
@ $0 |
|
| 06/08/2023 |
4
| Countouriotis Athena (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 51,955 options to buy
@ $0 |
|
| 06/08/2023 |
4
| MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 51,955 options to buy
@ $0 |
|
| 06/08/2023 |
4
| Maynard Ryan D (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 51,955 options to buy
@ $0 |
|
| 06/08/2023 |
4
| WEISER MICHAEL (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 51,955 options to buy
@ $0 |
|
| 06/08/2023 |
4
| Dukes Iain D. (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 103,911 options to buy
@ $0 |
|
| 06/08/2023 |
4
| YARNO WENDY L (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 12,988 options to buy
@ $0 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2023 |
4
| Vogt Frederick G (See Remarks) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 125,000 restricted stock units
@ $0
Granted 500,000 options to buy
@ $7.12, valued at
$3.6M
|
|
| 03/06/2023 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 46,875 restricted stock units
@ $0
Granted 93,750 options to buy
@ $7.12, valued at
$667.5k
|
|
| 03/06/2023 |
4
| BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 42,190 restricted stock units
@ $0
Granted 84,380 options to buy
@ $7.12, valued at
$600.8k
|
|
| 03/06/2023 |
4
| Bellemin Jean-Marc (CFO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 168,750 options to buy
@ $7.12, valued at
$1.2M
|
|
| 01/19/2023 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 4,678 shares
@ $6.43, valued at
$30.1k
Exercised 11,248 restricted stock units
@ $0 |
|
| 01/19/2023 |
4
| BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 4,671 shares
@ $6.43, valued at
$30k
Exercised 11,248 restricted stock units
@ $0 |
|
| 01/19/2023 |
4
| Vogt Frederick G (Interim CEO & General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 36,441 shares
@ $6.43, valued at
$234.3k
Exercised 83,325 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,023 shares
@ $6.11, valued at
$67.4k
Exercised 19,690 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 10,553 shares
@ $6.11, valued at
$64.5k
Exercised 18,850 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| Bellemin Jean-Marc (CFO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 10,553 shares
@ $6.11, valued at
$64.5k
Exercised 18,850 restricted stock units
@ $0 |
|
| 12/22/2022 |
4
| MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Bought 10,000 shares
@ $6.15, valued at
$61.5k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Bought 10,000 shares
@ $6.31, valued at
$63.1k
|
|
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Bought 10,000 shares
@ $6.18, valued at
$61.8k
|
|
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2022 |
4
| MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Exercised 40,000 options to buy
@ $5.65, valued at
$226k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Bellemin Jean-Marc (CFO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Exercised 18,850 shares
@ $0
Paid exercise price by delivering 9,346 shares
@ $7.73, valued at
$72.2k
Granted 18,850 options to buy
@ $0 |
|
| 06/16/2022 |
4
| BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Exercised 18,850 shares
@ $0
Paid exercise price by delivering 9,346 shares
@ $7.73, valued at
$72.2k
Granted 18,850 options to buy
@ $0 |
|
| 06/14/2022 |
4
| Countouriotis Athena (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 51,204 options to buy
@ $0 |
|
|
|
|